ES2168740T3 - Procedimiento de preparacion de derivados del acido 4h-4-oxo-quinolicina-3-carboxilico. - Google Patents
Procedimiento de preparacion de derivados del acido 4h-4-oxo-quinolicina-3-carboxilico.Info
- Publication number
- ES2168740T3 ES2168740T3 ES98904979T ES98904979T ES2168740T3 ES 2168740 T3 ES2168740 T3 ES 2168740T3 ES 98904979 T ES98904979 T ES 98904979T ES 98904979 T ES98904979 T ES 98904979T ES 2168740 T3 ES2168740 T3 ES 2168740T3
- Authority
- ES
- Spain
- Prior art keywords
- intermediate compound
- alkyl
- compound
- isolating
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un proceso para la preparación de un compuesto teniendo la fórmula: , en donde R 1 se selecciona del grupo que se compone de alquilo C1-C6, alquenilo C2-C6, alquinilo C2-C6, cicloalquilo C3-C6, fenilo, fluofenilo, difluofenilo, nitrofenilo, dinitrofenilo, y fluopiridilo; R 2 es alquilo C1-C3 o ciclopropilo; R 3 es cloro, bromo, yodo, metilsulfonato, trifluometilsulfonato o toluensulfonato; R 4 es fluor, cloro, bromo, o yodo; y R 5 es alquilo C1-C6; el método comprendiendo: (a) tratar un compuesto teniendo la fórmula: R 6 R 7 Q Q í N íí íí í í í j j R 1 , en donde R 1 es como se definió antes,R 6 y R 7 son alquilo C1-C6, o R 6 y R 7 son tomados conjuntamente con el átomo de nitrógeno al cual están unidos para formar un anillo morfolinilo, pirrolidinilo o piperidinilo, con un cloruro de ácido R 2 -CH2-CO-Cl, en donde R 2 es como se describió antes, y aislar un primer compuesto intermedio teniendo la estructura: , en donde R 1 , R 2 , R 6 y R 7 son como se describieron antes; (b) tratar secuencialmente el primer compuesto intermedio con una base, luego con 2-cianoacetamida, y aislar un segundo compuesto intermedio teniendo la estructura: , en donde R 1 y R 2 son como se definieron antes; (c) hidrolizar el grupo ciano del segundo compuesto intermedio con un ácido en un disolvente alcohólico R 5 -OH, en donde R 5 es como se describió antes, y aislar un tercer compuesto intermedio teniendo la estructura: , en donde R 1 y R 2 son como se describieron antes, y R 5 es alquilo C1-C6; (d) tratar el tercer compuesto intermedio con R 8 X, en donde R 8 es alquilo C1-C6, bencilo, bencilo sustituido, o trialquilsililo, y X es cloro, bromo, yodo, metilsulfonato, trifluometilsulfonato o toluensulfonato, y aislar un cuarto compuesto intermedio teniendo la estructura: ; (e) tratar secuencialmente el cuarto compuesto intermedio con una base de metal alcalino, luego con un compuesto de 3-alcoxi-acriloílo teniendo la fórmula: OR 9 j R 4 j Q Qí j j í íQ Q O Y , en donde R 4 es como se describió antes, R 9 es alquilo C1-C6 e Y es cloruro, bromuro, ciano, alcoxi o imidazol, y aislar un quinto compuesto intermedio teniendo la estructura: ; (f) ciclar el quinto compuesto intermedio con una cantidad catalítica de ácido, y aislar el sexto compuesto intermedio teniendo la estructura: ; y (g) tratar el sexto compuesto intermedio con un agente halogenante o sulfonante, y aislar el compuesto deseado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/806,806 US5693813A (en) | 1997-02-26 | 1997-02-26 | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2168740T3 true ES2168740T3 (es) | 2002-06-16 |
Family
ID=25194886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98904979T Expired - Lifetime ES2168740T3 (es) | 1997-02-26 | 1998-02-06 | Procedimiento de preparacion de derivados del acido 4h-4-oxo-quinolicina-3-carboxilico. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5693813A (es) |
| EP (1) | EP0971919B1 (es) |
| JP (1) | JP2001513104A (es) |
| KR (1) | KR20000075700A (es) |
| CN (1) | CN1248256A (es) |
| AR (1) | AR011167A1 (es) |
| AT (1) | ATE207920T1 (es) |
| AU (1) | AU724353B2 (es) |
| BG (1) | BG103737A (es) |
| BR (1) | BR9807726A (es) |
| CA (1) | CA2281734A1 (es) |
| CO (1) | CO4920239A1 (es) |
| CZ (1) | CZ290252B6 (es) |
| DE (1) | DE69802274T2 (es) |
| DK (1) | DK0971919T3 (es) |
| ES (1) | ES2168740T3 (es) |
| HU (1) | HUP0001323A3 (es) |
| IL (1) | IL131050A0 (es) |
| NO (1) | NO994108L (es) |
| NZ (1) | NZ336876A (es) |
| PL (1) | PL335373A1 (es) |
| PT (1) | PT971919E (es) |
| SK (1) | SK115299A3 (es) |
| TR (1) | TR199901956T2 (es) |
| TW (1) | TW444017B (es) |
| WO (1) | WO1998038191A1 (es) |
| ZA (1) | ZA98836B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
| CN106432222A (zh) * | 2016-09-19 | 2017-02-22 | 丹诺医药(苏州）有限公司 | 8‑氯‑1‑环丙基‑7‑氟‑9‑甲基‑4‑氧‑4‑氢‑喹嗪‑3‑羧酸酯及其制备方法 |
| CN106543170B (zh) * | 2016-10-27 | 2018-02-23 | 丹诺医药(苏州）有限公司 | 8‑氯‑1‑环丙基‑7‑氟‑9‑甲基‑4‑氧‑4‑氢‑喹嗪‑3‑羧酸酯及其合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726182A (en) * | 1990-05-02 | 1998-03-10 | Abbott Laboratories | Quinolizinone type compounds |
| IE911472A1 (en) * | 1990-05-02 | 1991-11-06 | Abbott Lab | Quinolizinone type compounds |
| BR9407806A (pt) * | 1993-10-14 | 1997-08-19 | Abbott Lab | Composto processo de tratamento de uma infecção bacteriana em um paciente humano ou veterinário e intermediário sintético |
| CA2222322A1 (en) * | 1995-06-06 | 1996-12-12 | Abbott Laboratories | Quinolizinone type compounds |
-
1997
- 1997-02-26 US US08/806,806 patent/US5693813A/en not_active Expired - Fee Related
-
1998
- 1998-02-02 ZA ZA98836A patent/ZA98836B/xx unknown
- 1998-02-06 PT PT98904979T patent/PT971919E/pt unknown
- 1998-02-06 SK SK1152-99A patent/SK115299A3/sk unknown
- 1998-02-06 AU AU62718/98A patent/AU724353B2/en not_active Ceased
- 1998-02-06 ES ES98904979T patent/ES2168740T3/es not_active Expired - Lifetime
- 1998-02-06 JP JP53766398A patent/JP2001513104A/ja active Pending
- 1998-02-06 KR KR1019997007767A patent/KR20000075700A/ko not_active Application Discontinuation
- 1998-02-06 TR TR1999/01956T patent/TR199901956T2/xx unknown
- 1998-02-06 IL IL13105098A patent/IL131050A0/xx unknown
- 1998-02-06 HU HU0001323A patent/HUP0001323A3/hu unknown
- 1998-02-06 CZ CZ19992881A patent/CZ290252B6/cs not_active IP Right Cessation
- 1998-02-06 DE DE69802274T patent/DE69802274T2/de not_active Expired - Fee Related
- 1998-02-06 EP EP98904979A patent/EP0971919B1/en not_active Expired - Lifetime
- 1998-02-06 BR BR9807726-0A patent/BR9807726A/pt not_active IP Right Cessation
- 1998-02-06 PL PL98335373A patent/PL335373A1/xx unknown
- 1998-02-06 AT AT98904979T patent/ATE207920T1/de not_active IP Right Cessation
- 1998-02-06 DK DK98904979T patent/DK0971919T3/da active
- 1998-02-06 NZ NZ336876A patent/NZ336876A/xx unknown
- 1998-02-06 CA CA002281734A patent/CA2281734A1/en not_active Abandoned
- 1998-02-06 CN CN98802785A patent/CN1248256A/zh active Pending
- 1998-02-06 WO PCT/US1998/002327 patent/WO1998038191A1/en not_active Application Discontinuation
- 1998-02-16 TW TW087102119A patent/TW444017B/zh not_active IP Right Cessation
- 1998-02-24 CO CO98009918A patent/CO4920239A1/es unknown
- 1998-02-25 AR ARP980100840A patent/AR011167A1/es unknown
-
1999
- 1999-08-25 NO NO994108A patent/NO994108L/no not_active Application Discontinuation
- 1999-09-16 BG BG103737A patent/BG103737A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA98836B (en) | 1998-08-05 |
| DE69802274T2 (de) | 2002-07-18 |
| JP2001513104A (ja) | 2001-08-28 |
| CZ290252B6 (cs) | 2002-06-12 |
| CN1248256A (zh) | 2000-03-22 |
| HUP0001323A2 (hu) | 2000-10-28 |
| TR199901956T2 (xx) | 1999-10-21 |
| WO1998038191A1 (en) | 1998-09-03 |
| DK0971919T3 (da) | 2002-01-28 |
| NZ336876A (en) | 2000-12-22 |
| TW444017B (en) | 2001-07-01 |
| AR011167A1 (es) | 2000-08-02 |
| ATE207920T1 (de) | 2001-11-15 |
| CO4920239A1 (es) | 2000-05-29 |
| EP0971919B1 (en) | 2001-10-31 |
| KR20000075700A (ko) | 2000-12-26 |
| AU6271898A (en) | 1998-09-18 |
| DE69802274D1 (de) | 2001-12-06 |
| NO994108L (no) | 1999-10-25 |
| PL335373A1 (en) | 2000-04-25 |
| IL131050A0 (en) | 2001-01-28 |
| HUP0001323A3 (en) | 2001-01-29 |
| AU724353B2 (en) | 2000-09-21 |
| EP0971919A1 (en) | 2000-01-19 |
| SK115299A3 (en) | 2000-01-18 |
| US5693813A (en) | 1997-12-02 |
| BG103737A (en) | 2000-06-30 |
| BR9807726A (pt) | 2000-02-15 |
| CZ288199A3 (cs) | 1999-11-17 |
| CA2281734A1 (en) | 1998-09-03 |
| NO994108D0 (no) | 1999-08-25 |
| PT971919E (pt) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2520447B2 (ja) | ４−アシルオキシ−３−ヒドロキシエチル−アゼチジノンの新規な製造方法 | |
| EA200400491A1 (ru) | Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции | |
| KR850008484A (ko) | 광학적 활성 알파-아릴알카노산의 제조방법 | |
| PL211695B1 (pl) | Sposób wytwarzania modafinilu | |
| ES2168740T3 (es) | Procedimiento de preparacion de derivados del acido 4h-4-oxo-quinolicina-3-carboxilico. | |
| AR007695A1 (es) | Procedimiento para preparar fenilheterociclos utiles como inhibidores de cox-2 | |
| Izquierdo et al. | Synthesis of E and Z 1-amino-2-aryl (alkyl)-cyclopropanecarboxylic acids via meldrum derivatives | |
| JPWO2005016880A1 (ja) | ｃｉｓ−４−フルオロ−Ｌ−プロリン誘導体の製造法 | |
| RU2003125271A (ru) | Способ получения фторированного сложного эфира, фторированного ацилфторида и фторированного винилового эфира | |
| JP2006513169A5 (es) | ||
| Kuroboshi et al. | Halofluorination of Alkenes Using Dilute Hydrofluoric Acid. | |
| US3726894A (en) | The compound 1-(2-hydroxyethyl)-4-phenyl-2-imidazolidinethione | |
| Okada et al. | Fluoro-lactonization of 4-alkenoic acid derivatives with N-fluoropentachloropyridinium triflate | |
| Cardellicchio et al. | Optically active sulfoxides by enantiospecific reactions of bromovinyl aryl sulfoxides with grignard reagents | |
| DK0610138T3 (da) | Fremgangsmåde til fremstilling af 6 alpha,9 alpha-difluorsteroider samt mellemprodukter dertil | |
| Hao et al. | Chemistry of nitroaziridines | |
| RU2007115091A (ru) | Способ получения соединений пурина | |
| US4368156A (en) | Preparation of 4-haloazetidin-2-ones from 4-sulfinoazetidin-2-ones | |
| Vadecard et al. | Chiral alcoholates in asymmetric synthesis: a renewal in the search for chiral bases | |
| EA200100894A1 (ru) | Новый способ получения алендроновой кислоты | |
| CN104817582A (zh) | 吡啶并异吲哚衍生物或苯并吡啶并异吲哚衍生物及其合成方法 | |
| IE64109B1 (en) | A process for the preparation of 4-halo-3-oxo-2-alkoxy-iminobutyric esters | |
| Hedhli et al. | Bromofluorination of vinyloxiranes | |
| Owen et al. | Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-substituted phenyl alkyl triazole-based compounds as potential inhibitors of 17α-hydroxylase/17, 20-lyase (P45017α) | |
| KANEKO et al. | Addition of molecular fluorine to azlactones: general synthetic method of erythro-β-fluorinated α-amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 971919 Country of ref document: ES |